Skip to main content

Schroeder Mark S's Form 4 filing

Labcorp Holdings Inc. (LH) · filed Mar 11, 2024

Accession no.
0001127602-24-009301
Filed
Mar 11, 2024
Trade date
Mar 7, 2024
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.10M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Schroeder Mark SCIK 0001793112Officer (EVP, Pres Diagnostics & COO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 7, 2024Common StockMOption exerciseAcquired+2,119$117.09+$248,113.7110,084.14Direct
Mar 7, 2024Common StockSSaleDisposed−5,048$218.45−$1,102,735.65,036.14Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 7, 2024Common StockMOption exerciseDisposed−2,119$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)